|
Weitz & Luxenberg Provides Information on Actos and the potential to develop bladder cancer which can result in death.
Are there bladder-cancer related deaths associated with Actos?
The FDA released a warning that there is a risk of developing bladder cancer in patients who take high dosages of Actos over a period of approximately 24 months or more. Bladder cancer ranks at the “4thmost common cancer among males and the 10th most common cancer among females.” (Johns Hopkins) It is estimated that over “50,000 people develop bladder cancer for various reasons, and more than 12,000 ultimately will die of the disease.” (Johns Hopkins)
“The French Public Health Insurance Office highlighted a potential risk of bladder cancer due to taking Actos.” (Reuters) This disconcerting discovery led to an Actos ban in France as well as in Germany, but the drug continues to remain on the American market.
The manufacturer of Actos, Takeda Pharmaceuticals has agreed to include the risk of bladder cancer on all Actos labels.
Actos is prescribed to treat patients suffering from type 2 Diabetes, which afflicts “over 18 million people in the United States.” (USA Today)
I’m worried. Should I stop taking Actos?
Medical professionals across the country are “urging Actos patients to continue to take the drug,” (USA Today) unless their personal physician instructs them to stop. Stuart Seides of Washington Hospital Center warned that “quitting Actos abruptly may be dangerous, and could cause a sudden increase in blood sugar.” (USA Today)
Note: Weitz & Luxenberg is not a medical institution so if you have any medically oriented inquiries, please direct them to your doctor.
How can Weitz & Luxenberg Assist Me?
The attorneys of Weitz & Luxenberg have been handling defective drug and medical device cases since 1986 and have achieved numerous verdicts and settlements on behalf of their clients. We are currently investigating Actos cases.
If you would like to tell us about your experience with Actos, please fill out the form on this page, and a representative from the firm will get back to you shortly.
Acknowledgements:
USA Today http://www.usatoday.com/news/health/2007-05-21-diabetes-drug-risks_N.htm
Reuters: http://www.reuters.com/article/2011/06/09/takeda-reaction-idUSN0914717920110609
Johns Hopkins: http://pathology2.jhu.edu/bladder_cancer/intro.cfm
see also:
Actos News
Actos and bladder cancer warning: Weitz & Luxenberg is investigating Actos causing bladder cancer floods the recent news: Weitz & Luxenberg attorneys are investigating
Actos Suspended in Europe
JAMA affirms Actos bladder cancer risks: File an Actos Lawsuit todayFile an Actos lawsuit today. Weitz & Luxenberg informs clients that Journal of American Medicine affirms risk of bladder cancer.
Actos Bladder Cancer
Actos Bladder Cancer and Actos Recall, Litigation, Lawyer and Lawsuits.A recent FDA warning implies that diabetes drug Actos could be related to instances of actos bladder cancer. Visit Weitz & Luxenberg to learn more.
